Respicardia
Developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD362—542m (Dealroom.co estimates Dec 2017.)
Minnetonka Minnesota (HQ)
Authorizing premium user...